Physician profile
Angela Ai
NPI 1982282364
$909.80
in general payments reported to CMS, 2019-2025
7 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $249 · 2024: $157 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.81 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $250.91 | 2023-2024 | Fetroja |
| Alexion Pharmaceuticals, INC. | $222.40 | 2025 | Ultomiris, Soliris |
| Springworks Therapeutics, INC. | $134.10 | 2025 | Ogsiveo |
| Amgen INC. | $125.00 | 2022 | |
| Melinta Therapeutics, LLC | $124.29 | 2023 | Kimyrsa |
| Adc Therapeutics America, INC. | $30.60 | 2024 | |
| Adaptive Biotechnologies Corporation | $22.50 | 2025 | Clonoseq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Ai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.